STOCKHOLDERS’ EQUITY (Tables)

12 Months Ended

Dec. 31, 2023

A summary of the stock option activity is presented below:

SCHEDULE OF STOCK OPTIONS

	Options Outstanding as of December 31, 2023
	Number of Shares Subject to Options		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in years)		Aggregate Intrinsic Value
Balance at December 31, 2022		346,854	$	2.80		3.57		-
Options granted		205,000		0.21		4.11		-
Options exercised		-		-		-		-
Options canceled / expired		-		-		-		-
Balance at December 31, 2023		551,854	$	1.841		3.04	$	-

Vested and exercisable at December 31, 2023		551,854	$	1.84		3.70	$	2,500

A summary of the Company’s outstanding warrants is presented below:

SCHEDULE OF WARRANTS OUTSTANDING

	Warrants Outstanding as of December 31, 2023
	Number of Shares Subject to Warrants		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (in years)		Aggregate Intrinsic Value

Balance on December 31, 2022		1,117,092	$	2.02		4.05		-
Options granted		-		-		-		-
Options exercised		-		-		-		-
Options canceled / expired		12,851		-		-		-
Balance at December 31, 2023		1,104,243	$	1.79		3.10	$	-

Vested and exercisable at December 31, 2023		1,104,243	$	1.79		3.10	$	-

A summary of the restricted stock activity is presented below:

SUMMARY OF RESTRICTED STOCK

	Restricted Stock Common Stock
Balance at December 31, 2022		107,993
Balance at December 31, 2023		1,793,483

PANACEA LIFE SCIENCES HOLDINGS, INC. 10-K